FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-131 | 71449-131-15 | Dexmedetomidine Hydrochloride | 4 ug/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-131 | 71449-131-11 | Dexmedetomidine Hydrochloride | 4 ug/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-106 | 71449-106-11 | Ephedrine Sulfate | 5 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-106 | 71449-106-15 | Ephedrine Sulfate | 5 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-134 | 71449-134-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 5 ug/1 mL; 3.75 mg/1 mL; .1 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-013 | 71449-013-32 | Fentanyl Citrate | 50 ug/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-013 | 71449-013-05 | Fentanyl Citrate | 50 ug/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-072 | 71449-072-41 | Fentanyl Citrate | 10 ug/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-072 | 71449-072-82 | Fentanyl Citrate | 10 ug/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-104 | 71449-104-11 | Glycopyrrolate | .2 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-018 | 71449-018-32 | Hydromorphone | 1 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-068 | 71449-068-32 | Ketamine | 10 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-068 | 71449-068-11 | Ketamine | 10 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 20 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 10 mg/1 mL; 15 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 5 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-022 | 71449-022-32 | Morphine Sulfate | 5 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 5 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 1 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-103 | 71449-103-11 | Neostigmine Methylsulfate | 1 mg/1 mL | 2022-2 | valid | 2026-11-08 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 3 mg/7 mg; 4 mg/7 mg | 2022-2 | valid | 2026-11-08 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-880 | 69852-880-10 | Brompheniramine Maleate | 10 mg/10 mg | 2022-2 | valid | 2026-11-08 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-496 | 69852-496-10 | Triamcinolone Acetonide | 80 mg/80 mg | 2022-2 | valid | 2026-11-08 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-691 | 69852-691-10 | Triamcinolone Acetonide | 50 mg/50 mg | 2022-2 | valid | 2026-11-08 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-776 | 69852-776-10 | Dexamethasone Acetate Anhydrous | 8 mg/8 mg | 2022-2 | valid | 2026-11-08 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 30 mg/30 mg | 2022-2 | valid | 2026-11-08 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 80 mg/80 mg | 2022-2 | valid | 2026-11-08 | ||
| "Eagle Pharmacy, Inc.(038598540)" | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 40 mg/40 mg | 2022-2 | valid | 2026-11-08 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9904 | 51754-9904-1 | Potassium Acetate | 200 meq/100 mL | 2022-2 | valid | 2026-11-08 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9995 | 51754-9995-1 | Sodium Acetate | 200 meq/100 mL | 2022-2 | valid | 2026-11-08 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9160 | 51754-9160-1 | Fentanyl Citrate | 5000 ug/100 mL | 2022-2 | valid | 2026-11-08 | ||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg/.165 g; 25 mg/.165 g; 3 mg/.165 g | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 25 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate | 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate | .75 mg/1 mL; 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin; Tobramycin | 50 mg/1 mL; 15 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Cyclosporine | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; .4 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 7.5 mg/1 mL; .25 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ascorbic Acid | 500 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2022-2 | source_no_ndc | 2026-11-08 |